SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 315.85 |
| Enterprise Value ($M) | 222.77 |
| Book Value ($M) | 316.69 |
| Book Value / Share | 2.10 |
| Price / Book | 1.00 |
| NCAV ($M) | 242.06 |
| NCAV / Share | 1.60 |
| Price / NCAV | 1.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.34 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.26 |
| Current Ratio | 12.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 320.68 |
| Assets | 395.30 |
| Liabilities | 78.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -141.53 |
| Net Income | -125.04 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -101.22 |
| Cash from Investing | -91.22 |
| Cash from Financing | 1.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 5.36 | ||
| 13G/A | City Hill, LLC | 21.80 | 9.35 | |
| 13D/A | Cormorant Asset Management, LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 57,146 | 508,102 | 11.25 | |
| 70,604 | 187,890 | 37.58 | |
| 93,719 | 113,832 | 82.33 | |
| 110,036 | 161,450 | 68.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELEV – Elevation Oncology, Inc. | ELVN – Enliven Therapeutics, Inc. |
| ENTA – Enanta Pharmaceuticals, Inc. | EWTX – Edgewise Therapeutics, Inc. |
| EXEL – Exelixis, Inc. |
Financial data and stock pages provided by
Fintel.io